QCC374

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for QCC374, covering 2016-03-22 to 2020-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients [Phase 2]